Page last updated: 2024-08-24

technetium tc 99m mertiatide and Carcinoma, Squamous Cell

technetium tc 99m mertiatide has been researched along with Carcinoma, Squamous Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerretsen, M; Herscheid, JD; Snow, GB; van Dongen, G; Visser, GW1
Klok, R; Snow, GB; van der Schors, R; van Dongen, GA; van Gog, FB; Visser, GW1

Other Studies

2 other study(ies) available for technetium tc 99m mertiatide and Carcinoma, Squamous Cell

ArticleYear
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:11

    Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Rhenium; Technetium Tc 99m Mertiatide

1993
Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2

    Topics: Animals; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Mice; Mice, Nude; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Rhenium; Technetium Tc 99m Mertiatide; Tissue Distribution

1996